2024 Saxenda information leaflet

Saxenda information leaflet

Author: ydsh

August undefined, 2024

WebSaxenda, caution should be exercised when supplying to patients with thyroid disease. Ongoing support • Treatment with Saxenda should only be considered if dietary and physical activity interventions have been evaluated. It is vital that Saxenda is used as part of an integrated approach to weight management, with the appropriate support, Web• Recommended dose of Saxenda is 3 mg daily. Administer at any time of day, without regard to the timing of meals (2). • Initiate at 0.6 mg per day for one week. In weekly …

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

WebWhat is in this leaflet. 1. What Saxenda is and what it is used for. 2. What you need to know before you use Saxenda. 3. How to use Saxenda. 4. Possible side effects. 5. How to store … WebSAXENDA is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial Body Mass Index (BMI) of:,- greater than or equal to 30 kg/m2 ( obese) or,- greater than or equal to 27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight related comorbidity, … rawtenstall post office collection times

Why am I Not Losing Weight on Saxenda? Asda Online Doctor

WebApr 26, 2024 · After 12 weeks of taking Saxenda at the full 3mg per day dose, most people will have lost at least 5% of their starting body weight. It can be helpful to think about how Saxenda works. Saxenda works by affecting your appetite. The … WebKeep this leaflet with the medicine. You may need to read it again. What Saxenda ® is and what it is used for . Saxenda ® is a weight loss medicine that contains the active … rawtenstall post office collection office

Consumer Medicines Information (CMI) - Therapeutic Goods …

WebJan 20, 2024 · Saxenda Package leaflet v7-April2024-clean_1621955795.pdf. Reasons for updating. Change to section 1 - what the product is used for ; ... Text updated to include information on dizziness: " Saxenda has no or negligible influence on the ability to drive and use machines. However, dizziness can be experienced mainly during the first 3 months of ... WebPATIENT MEDICATION INFORMATION. SAXENDA® (liraglutide) Read this carefully before you start taking SAXENDA® and each time you get a refill. This leaflet is a summary and will not tell you everything about this drug. Talk to your healthcare professional about your medical condition and treatment and ask if there is any new information about ... rawtenstall post office phone numberWebThe most common side effects with Saxenda (which may affect more than 1 in 10 people) are nausea (feeling sick), vomiting, diarrhoea and constipation. For the full list of all side … rawtenstall post office depot

"WebConsumer Medicine Information (CMI) This leaflet provides important information about using Saxenda®. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about using Saxenda®. Where to find information in this leaflet: 1. Why am I using Saxenda®? 2. " - Saxenda information leaflet

Saxenda information leaflet

WebSaxenda is a medication for chronic weight management. It is for people with overweight and weight-related complications or obesity. It is meant to be used together with a … WebAfter using Saxenda® Product description Further information Instructions for use harm your unborn child. This leaflet answers some common questions about Saxenda®. It does not contain all the available information. It does not take the place of talking to your doctor, nurse or pharmacist. milk. Do not use Saxenda® if you are breast

Did you know?

WebSep 16, 2024 · It is used in addition to other antidiabetic medicines. Liraglutide, in the brand Saxenda®, can also be used to manage obesity and weight loss together with a reduced … WebJan 20, 2024 · Active Ingredient (s): Liraglutide. *Additional information is available within the SPC or upon request to the company. SPC. Patient Leaflets. Licence Info. Doc History. Summary of Product Characteristics last updated on …

WebFeb 21, 2024 · The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. Last updated on emc: 21 Feb 2024. View or print the patient leaflet as PDF. … WebSaxenda (liraglutide) is a prescription medication that is used as an adjunct to a reduced-calorie diet and increased physical activity for the treatment of obesity in adults. It is a type of medication called a glucagon-like peptide-1 (GLP-1) receptor agonist, which works by regulating appetite and food intake.

WebSaxenda® should not be used in children and adolescents under 18 years of age. This is because the effects of Saxenda have not been studied in this age group. Using Saxenda … WebThis leaflet answers some common questions about Saxenda ®. It does not contain all the available information. It does not take the place of talking to your doctor, nurse or …

WebConsumer Medicine Information . What is in this leaflet . What Saxenda ® is and what it is used for ..... 1 Before you use Saxenda ®..... 1 How to use Saxenda ®..... 2 While you are using Saxenda ®. 3 Things to be careful of..... 3 Side effects..... 3 After using Saxenda ®

WebSAXENDA® (liraglutide) is used for weight loss in adults aged 18 and above who have either: • BMI* of 30 or greater (obese - very overweight), or • BMI* of 27-30 (overweight) in the … rawtenstall railwayWebFeb 13, 2024 · Saxenda ( liraglutide) is used for weight loss and to help keep weight off once weight has been lost, it is used for obese adults or overweight adults who also have weight-related medical problems. Saxenda can be used in children aged 12 to 17 years who with obesity and who have a bodyweight above 132 pounds (60 kg). rawtenstall pubsWebDec 9, 2024 · Information about liraglutide . Marketing authorisation . 2.1 . Liraglutide (Saxenda, Novo Nordisk) is indicated 'as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial BMI of ≥30 kg/m² (obese), or ≥27 kg/m² to <30 kg/m² (overweight) in the presence of at least one rawtenstall railway stationWebSaxenda ® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity … simple map of australia with capital citiesWebSaxenda is a glucagon- like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients... rawtenstall registration officeWebWhat Saxenda® is and what it is used for Saxenda® is a weight loss medicine that contains the active ingredient liraglutide. It is similar to a naturally occurring hormone called GLP-1 … rawtenstall rugby clubWebSaxenda® is an injectable medicine used for adults with excess weight who may also have weight-related medical problems or obesity and children aged 12-17 years with a body … rawtenstall screwfix